Carl Pearson, PhD

Research Fellow

Research theme: Rapid Response to Emerging Threats

Carl is a Research Fellow at the London School of Hygiene & Tropical Medicine, and a member of the Centre for Mathematical Modelling of Infectious Disease (CMMID). He is a regular contributor to the efforts by the CMMID COVID-19 working group, and also works on Ebola, Dengue, and various other infectious diseases. He primary research approaches use high performance computing to simulate fundamental infectious disease processes and forecast disease and economic impacts of public health interventions. He is most interested in questions concerning operational public health decision-making.

ORCID ID: 0000-0003-0701-7860

Recent publications

Evaluating targeted COVID-19 vaccination strategies with agent-based modeling
Hladish TJ, Pillai AN, Pearson CAB, Toh KB, Tamayo A, Stoltzfus A, Longini Jr IM

PLOS Computational Biology

(2024)

https://doi.org/10.1371/journal.pcbi.1012128
Accumulation of immunity in heavy-tailed sexual contact networks shapes Mpox outbreak sizes
Murayama H, Pearson CAB, Abbott S, Miura F, Jung S, Fearon E, Funk S, Endo A

Journal of Infectious Diseases

(2024)

https://doi.org/10.1093/infdis/jiad254
Multiple models for outbreak decision support in the face of uncertainty
Shea K, Borchering RK, Probert WJM, Howerton E, Bogich T, Li S, Van Panhuis WG, Viboud C, Aguas R, Pearson CAB, et al

Proceedings of the National Academy of Sciences

(2023)

https://doi.org/10.1073/pnas.2207537120
What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria
Ruiz F, Torres-Rueda S, Pearson CAB, Bergren E, Okeke C, Procter SR, Madriz-Montero A, Jit M, Vassall A, Uzochukwu B

PLOS Global Public Health

(2023)

https://doi.org/10.1371/journal.pgph.0001693
Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries
Liu Y, Procter SR, Pearson CAB, Montero AM, Torres-Rueda S, Asfaw E, Uzochukwu B, Drake T, Bergren E, Eggo RE, Ruiz F, Ndembi N, Nonvignon J, Jit M, Vassall A

BMC Medicine

(2023)

https://doi.org/10.1186/s12916-023-02784-z
Heavy-tailed sexual contact networks and monkeypox epidemiology in the global outbreak, 2022
Endo A, Murayama H, Abbott S, Ratnayake R, Pearson CAB, Edmunds WJ, Fearon E, Funk S

Science

(2022)

https://doi.org/10.1126/science.add4507
Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo
Pearson CAB, Edmunds WJ, Hladish TJ, Eggo RE

International Journal of Epidemiology

(2022)

https://doi.org/10.1093/ije/dyab172
Bounding the levels of transmissibility & immune evasion of the Omicron variant in South Africa
Pearson CAB, Silal SP, Li MWZ, Dushoff J, Bolker BM, Abbott S, van Schalkwyk C, Davies NG, Barnard RC, Edmunds WJ, Bingham JL, Meyer-Rath G, Glass A, Wolter N, Govender N, Stevens W, Scott L, Mlisana K, Moultrie H, Pulliam JRC

medRxiv

(2021)

https://doi.org/10.1101/2021.12.19.21268038
Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries
Torres-Rueda S, Sweeney S, Bozzani F, Naylor NR, Baker T, Pearson CAB, Eggo R, Procter SR, Davies N, Quaife M, Kitson N, Keogh-Brown MR, Jensen HT, Saadi N, Khan M, Huda M, Kairu A, Zaidi R, Barasa E, Jit M, Vassall A

BMJ Global Health

(2021)

https://doi.org/10.1136/bmjgh-2021-005759
COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectiveness
Pearson CAB, Bozzani F, Procter SR, Davies NG, HudaI M, Jensen HT, Keogh-Brown M, Khalid M, Sweeney S, Torres-Rueda S, CHiL COVID-19 Working Group, CMMID COVID-19 Working Group, Eggo RM, Vassall A, Jit M

PLoS Medicine

(2021)

https://doi.org/10.1371/journal.pmed.1003815